Haemonetics (HAE) Tops Q2 EPS by 16c; offers guidance
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $108.40 -0.37%
Financial Fact:
Selling, general and administrative: 71.12M
Today's EPS Names:
XYF, SQZB, RENO, More
Financial Fact:
Selling, general and administrative: 71.12M
Today's EPS Names:
XYF, SQZB, RENO, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $1.27, $0.16 better than the analyst estimate of $1.11. Revenue for the quarter came in at $327 million versus the consensus estimate of $311.46 million.
GUIDANCE:
Haemonetics sees FY2026 EPS of $4.80-$5.00, versus the consensus of $4.83.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aggreko files for proposed IPO
- Co-Diagnostics (CODX) files for 3.4M share offering by selling stockholders
- Golden Spike Resources expands private placement to $975,000
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
